Immunovia Announces Positive Results from the IMMray[™] PanCan-d Verification Study
LUND, SWEDEN – Immunovia, a diagnostic company that develops highly accurate blood tests for the early detection of cancer and autoimmune diseases, today announced positive results from the verification study and will now commence the validation study, the last step towards the launch of IMMray[™] PanCan-d. The verification study analysis shows results in line with the previous commercial test model study (CTMS), which paves the way for the final blinded validation study. “We are very pleased with the results of the verification study and are now commencing the preparation for the